Top Markets
#1 MowCat MowCat +369.66%
#2 龙虾 (Lobster) 龙虾 (Lobster) +69.28%
#3 SODAX SODAX +47.24%
#4 Cortex Cortex +34.04%
#5 DexNet DexNet +23.19%
#6 OpenEden OpenEden +22.02%
#7 Akedo Akedo +16.91%
#8 Magma Finance Magma Finance +16.22%
#9 wojak wojak +15.96%
#10 MANTRA MANTRA +15.77%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Össur hf. Össur hf.

Össur hf.

OSSR
Rangering i aksjer #7166
Össur hf. and its subsidiaries are actively involved in the creation,... Össur hf. and its subsidiaries are actively involved in the creation, advancement, manufacturing, and global distribution of non-invasive orthopedic medical devices. Their reach extends across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's operations are divided into two main business units: Prosthetics and Bracing & Supports. The Prosthetics division supplies both mechanical devices, such as lower limb and finger prostheses, and cutting-edge bionic products. These bionic solutions, designed for amputees, incorporate microprocessor-controlled feet, knees, hands, liners, and other integrated components featuring sensors, computing power, intrinsic intelligence, and actuators. In contrast, the Bracing & Supports segment offers a variety of supportive equipment for areas like the spine, knees, hips, feet, ankles, and hands. These products serve both therapeutic and preventative purposes by stabilizing joints and other body parts, in addition to providing injury management solutions to aid the healing of fractures and ligament injuries. Össur's primary customer base consists of specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgical centers. The company distributes its offerings through a combination of its own direct sales force and a network of third-party distributors. Founded in 1971 and headquartered in Reykjavik, Iceland, Össur hf. operates as a subsidiary of William Demant Invest A/S.
Aksjekurs
$4.26
Sist synkronisert: 2024-05-03
Markedsverdi
$1.70B
Endring (1 dag)
0.99%
Endring (1 år)
0.00%
Land
IS
Handel Össur hf. (OSSR)

Kategori

Healthcare
P/E-forhold for Össur hf. (OSSR)
P/E-forhold per 2026 TTM: 0
Ifølge Össur hf. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for Össur hf. fra 2026 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
Ikke nok data for de angitte datoene.
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.